33 results
8-K
EX-1.1
INZY
Inozyme Pharma Inc
28 Jul 23
Inozyme Pharma, Inc. Announces Pricing of Public Offering of Common Stock
5:19pm
Retirement Income Security Act of 1974, as amended, and the regulations and published interpretations promulgated thereunder (collectively, “ERISA … the Company nor any of its subsidiaries have any “accumulated post-retirement benefit obligations” (within the meaning of Statement of Financial Accounting
8-K
EX-10.1
nf34qucj4atj6
8 Dec 22
Departure of Directors or Certain Officers
4:14pm
8-K
EX-1.1
lltaonzw
19 Apr 22
Inozyme Pharma Announces $73 Million Underwritten Offering Priced At-the-Market
7:30am
S-3
EX-4.4
9wse9 zsgk48k4tl
11 Aug 21
Shelf registration
7:12am
S-3
EX-1.2
4gyxtdu
11 Aug 21
Shelf registration
7:12am
S-3
EX-4.3
0n4dd9tv4npu1m8c
11 Aug 21
Shelf registration
7:12am
DEF 14A
7tn7e8a8d2gk86xs633o
27 Apr 21
Definitive proxy
7:30am
8-K
EX-3.1
qwnon80zq
28 Jul 20
Amendments to Articles of Incorporation or Bylaws
4:01pm
424B4
77c3c 8kvx6rqmytc2
24 Jul 20
Prospectus supplement with pricing info
4:01pm